Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review
Article in HepatoBiliary Surgery and Nutrition (February 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Sequencing Systemic Therapy in Hepatocellular Carcinoma
Article in Current Treatment Options in Oncology (October 2023)
Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1
Article in Cancer Biology & Therapy (September 2023)